Skip directly to site content
Are You Still There?
Due to inactivity, you will be signed out in two minutes unless you click 'Continue'.

Are you still there?

Due to inactivity, you will be signed out in two minutes unless
you click 'Continue'.

AR Isolate Bank Citations

The following are peer-reviewed publications that cite the CDC & FDA AR Isolate Bank.

If you have published your work using AR Isolate Bank isolates, we would like to hear about it. Please email us at ARbank@cdc.gov to share the title, publication information, and link or DOI.

References to non-CDC sites on the Internet are provided as a service to the CDC and FDA AR Isolate Bank readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed on this page were current as of the date of publication.

1.
A novel platform to accelerate antimicrobial susceptibility testing in Neisseria gonorrhoeae using RNA signatures
Hashemi MM, Ram-Mohan N, Yang X, Andini N, Gessner NR, Carroll KC, Wang TH, Yang S
Journal of Clinical Microbiology Sep 2020, JCM.01152-20;
DOI: https://doi.org/10.1128/JCM.01152-20       
2.
Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens
Kirby JE, Brennan-Krohn T, Smith K
Journal of Clinical Microbiology Nov 2019, 57 (12) e01270-19;
DOI: https://doi.org/10.1128/JCM.01270-19       
3.
Direct Detection of Emergent Fungal Pathogen Candida auris in Clinical Skin Swabs by SYBR Green-Based Quantitative PCR Assay
Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP
Journal of Clinical Microbiology Nov 2018, 56 (12) e01337-18;
DOI: https://doi.org/10.1128/JCM.01337-18       
4.
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model
Asempa TE, Motos A, Abdelraouf K, Bissantz C, Zampaloni C, Nicolau DP
Antimicrobial Agents and Chemotherapy Mar 2019, 63 (4) e02382-18;
DOI: https://doi.org/10.1128/AAC.02382-18       
5.
Evaluation of Calcium-Enhanced Media for Colistin Susceptibility Testing by Gradient Agar Diffusion and Broth Microdilution
Green DA, Macesic N, Uhlemann AC, Lopez M, Stump S, Whittier S, Schuetz AN, Simner PJ, Humphries RM
Journal of Clinical Microbiology Jan 2020, 58 (2) e01522-19;
DOI: https://doi.org/10.1128/JCM.01522-19       
6.
Evaluation of the NG-Test MCR-1 Lateral Flow Assay and EDTA-Colistin Broth Disk Elution Methods to Detect Plasmid-Mediated Colistin Resistance among Gram-Negative Bacterial Isolates
Fenwick AJ, Bergman Y, Lewis S, Yee R, Uhlemann AC, Cole N, Kohner P, Ordak C, Green DA, Schuetz AN, Humphries R, Simner PJ
Journal of Clinical Microbiology Mar 2020, 58 (4) e01823-19;
DOI: https://doi.org/10.1128/JCM.01823-19       
7.
Evaluation of the Rapid Polymyxin NP Test for Polymyxin B Resistance Detection Using Enterobacter cloacae and Enterobacter aerogenes Isolates
Simar S, Sibley D, Ashcraft D, Pankey G
Journal of Clinical Microbiology Sep 2017, 55 (10) 3016-3020;
DOI: https://doi.org/10.1128/JCM.00934-17       
8.
Exploration of the Neisseria resistome reveals resistance mechanisms in commensals that may be acquired by N. gonorrhoeae through horizontal gene transfer
Fiore MA, Raisman JC, Wong NH, Hudson AO, Wadsworth CB
bioRxiv 2020.07.30.228593;
DOI: https://doi.org/10.1101/2020.07.30.228593       
9.
Imipenem-Relebactam Susceptibility Testing of Gram-Negative Bacilli by Agar Dilution, Disk Diffusion, and Gradient Strip Methods Compared with Broth Microdilution
Hakvoort H, Bovenkamp E, Greenwood-Quaintance KE, Schmidt-Malan SM, Mandrekar JN, Schuetz AN, Patel R
Journal of Clinical Microbiology Sep 2020, 58 (10) e00695-20;
DOI: https://doi.org/10.1128/JCM.00695-20       
10.
Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris
Welsh RM, Sexton DJ, Forsberg K, Vallabhaneni S, Litvintseva A
Journal of Clinical Microbiology Mar 2019, 57 (4) e00007-19;
DOI: https://doi.org/10.1128/JCM.00007-19       
11.
Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned
Zhu YC, O’Brien B, Leach L, Clarke A, Bates M, Adams E, Ostrowsky B, Quinn M, Dufort E, Southwick K, Erazo R, Haley VB, Bucher C, Chaturvedi V, Limberger R, Blog D, Lutterloh E, Chaturvedi S
Journal of Clinical Microbiology Mar 2020, 58 (4) e01503-19;
DOI: https://doi.org/10.1128/JCM.01503-19       
12.
Locus CauMT1 Provides a Higher-Resolution Alternative to Ribosomal Gene Sequencing for Initial Candida auris Genotyping
Katiyar S, Edlind T
Journal of Clinical Microbiology Aug 2020, 58 (9) e01039-20;
DOI: https://doi.org/10.1128/JCM.01039-20       
13.
Misidentification of Candida auris by RapID Yeast Plus, a Commercial, Biochemical Enzyme-Based Manual Rapid Identification System
Snayd M, Dias F, Ryan RW, Clout D, Banach DB
Journal of Clinical Microbiology Apr 2018, 56 (5) e00080-18;
DOI: https://doi.org/10.1128/JCM.00080-18       
14.
Multicenter Evaluation of Colistin Broth Disk Elution and Colistin Agar Test: a Report from the Clinical and Laboratory Standards Institute
Humphries RM, Green DA, Schuetz AN, Bergman Y, Lewis S, Yee R, Stump S, Lopez M, Macesic N, Uhlemann AC, Kohner P, Cole N, Simner PJ
Journal of Clinical Microbiology Oct 2019, 57 (11) e01269-19;
DOI: https://doi.org/10.1128/JCM.01269-19       
15.
Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against mcr-1-Mediated Polymyxin-Resistant Escherichia coli In Vivo
Soon SH, Kaufmann Y, Huang E
Antimicrobial Agents and Chemotherapy Mar 2020, 64 (4) e02045-19;
DOI: https://doi.org/10.1128/AAC.02045-19       
16.
Performance Evaluation of Culture-Independent SYBR Green Candida auris Quantitative PCR Diagnostics on Anterior Nares Surveillance Swabs
Georgacopoulos O, Nunnally NS, Le N, Lysen C, Welsh RM, Kordalewska M, Perlin DS, Berkow EL, Sexton DJ
Journal of Clinical Microbiology Aug 2020, 58 (9) e00690-20;
DOI: https://doi.org/10.1128/JCM.00690-20       
17.
Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates
Smith EC, Brigman HV, Anderson JC, Emery CL, Bias TE, Bergen PJ, Landersdorfer CB, Hirsch EB
Journal of Clinical Microbiology Sep 2020, 58 (10) e01121-20;
DOI: https://doi.org/10.1128/JCM.01121-20       
18.
Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels
Ransom E, Bhatnagar A, Patel JB, Machado MJ, Boyd S, Reese N, Lutgring JD, Lonsway D, Anderson K, Brown AC, Elkins CA, Rasheed JK, Karlsson M
Journal of clinical microbiology Mar 2020, 58(4), e01944-19.
https://doi.org/10.1128/JCM.01944-19       
19.
Variability in Zinc Concentration among Mueller-Hinton Broth Brands: Impact on Antimicrobial Susceptibility Testing of Metallo-β-lactamase-producing Enterobacteriaceae
Bilinskaya A, Buckheit DJ, Gnoinski M, Asempa TE, Nicolau DP
Journal of Clinical Microbiology Sep 2020, JCM.02019-20;
DOI: https://doi.org/10.1128/JCM.02019-20       
20.
We Cannot Do It Alone: The Intersection of Public Health, Public Policy, and Clinical Microbiology
Lee RA, Kirby JE
Clinics in Laboratory Medicine Volume 39, Issue 3, Sep 2019, Pages 499-508;
https://doi.org/10.1016/j.cll.2019.05.008       
21.
Micafungin and amphotericin B synergy against Candida auris
Jaggavarapu S, Burd EM, Weiss DS
The Lancet Microbe, Volume 1, Issue 8, 2020, Pages e314-e315, ISSN 2666-5247;
DOI: https://doi.org/10.1016/S2666-5247(20)30194-4       
22.
Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice
Becker K, Aranzana-Climent V, Cao S, Nilsson A, Shariatgorji R, Haldimann K, Platzack B, Hughes D, Andrén PE, Böttger EC, Friberg LE, Hobbie SN
Clinical Microbiology and Infection, Volume 27, Issue 9, 2021, Pages 1315-1321, ISSN 1198-743X;
DOI: https://doi.org/10.1016/j.cmi.2020.12.004       
23.
Synergistic Combinations and Repurposed Antibiotics Active against the Pandrug-Resistant Klebsiella pneumoniae Nevada Strain
Brennan-Krohn T, Kirby JE
Antimicrob Agents Chemother. 2019 Aug 23;63(9):e01374-19.
DOI: https://doi.org/10.1128/AAC.01374-19       
PMID: 31307981; PMCID: PMC6709503.
24.
A Whole-Cell Screen for Adjunctive and Direct Antimicrobials Active against Carbapenem-Resistant Enterobacteriaceae
Smith KP, Dowgiallo MG, Chiaraviglio L, Parvatkar P, Kim C, Manetsch R, Kirby JE.
SLAS Discov. 2019 Sep;24(8):842-853.
DOI: https://doi.org/10.1177/2472555219859592       
Epub 2019 Jul 3. PMID: 31268804; PMCID: PMC6702050.
25.
Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae
Riedel S, Vijayakumar D, Berg G, Kang AD, Smith KP, Kirby JE
J Antimicrob Chemother. 2019 May 1;74(5):1311-1316.
DOI: https://doi.org/10.1093/jac/dkz012       
PMID: 30689929; PMCID: PMC6477976
26.
Synergistic Activity of Colistin- Containing Combinations against Colistin-Resistant Enterobacteriaceae
Brennan-Krohn T, Pironti A, Kirby JE
Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00873-18.
DOI: https://doi.org/10.1128/AAC.00873-18       
PMID: 30061285; PMCID: PMC6153801.
27.
Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin- intermediate Staphylococcus aureus clinical isolates
Truelson KA, Brennan-Krohn T, Smith KP, Kirby JE
Diagn Microbiol Infect Dis. 2018 Oct;92(2):168-171.
DOI: https://doi.org/10.1016/j.diagmicrobio.2018.05.018       
Epub 2018 May 29. PMID: 29934071; PMCID: PMC6131043.
28.
The Inoculum Effect in the Era of Multidrug Resistance: Minor Differences in Inoculum Have Dramatic Effect on MIC Determination
Smith KP, Kirby JE
Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00433-18.
DOI: https://doi.org/10.1128/AAC.00433-18       
PMID: 29784837; PMCID: PMC6105823.
29.
Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model
Kang AD, Smith KP, Berg AH, Truelson KA, Eliopoulos GM, McCoy C, Kirby JE
Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02585-17.
DOI: https://doi.org/10.1128/AAC.02585-17       
PMID: 29339396; PMCID: PMC5913965.
30.
Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology
Brennan-Krohn T, Truelson KA, Smith KP, Kirby JE
J Antimicrob Chemother. 2017 Oct 1;72(10):2775-2781.
DOI: https://doi.org/10.1093/jac/dkx241        .
PMID: 29091221; PMCID: PMC5890738.
31.
In vitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
Kang AD, Smith KP, Eliopoulos GM, Berg AH, McCoy C, Kirby JE
Diagn Microbiol Infect Dis. 2017 Jun;88(2):188-191.
DOI: https://doi.org/10.1016/j.diagmicrobio.2017.03.006       
Epub 2017 Mar 16. PMID: 28341099.
32.
Direct Detection of Intact Klebsiella Pneumoniae Carbapenemase Variants from Cell Lysates: Identification, Characterization and Clinical Implications
McGee WM, Faron ML, Neil JR, Kronewitter SR, Buchan BW, Ledeboer NA, Stephenson Jr. JL
Clinical Mass Spectrometry. 2020 Jul 28.
DOI: https://doi.org/10.1016/j.clinms.2020.07.001       
33.
A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii
Luna B, Trebosc V, Lee B et al.
Nat Microbiol 5, 1134–1143 (2020).
DOI: https://doi.org/10.1038/s41564-020-0737-6       
34.
Comparative Evaluations of the Pathogenesis of Candida auris Phenotypes and Candida albicans Using Clinically Relevant Murine Models of Infections
Vila T, Montelongo-Jauregui D, Ahmed H, Puthran T, Sultan AS, Jabra-Rizk MA, Mitchell AP, Editor.
DOI: https://doi.org/10.1128/mSphere.00760-20       
35.
Micafungin and amphotericin B synergy against Candida auris
Jaggavarapu S, Burd EM, Weiss DS
The Lancet: Microbe. Vol 1, Issue 8, E314-E315(2020)
DOI: https://doi.org/10.1016/S2666-5247(20)30194-4       
36.
In Vitro Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B
Wu Y et al.
Antimicrobial agents and chemotherapy vol. 64,2 e02063-19. 27 Jan. 2020,
DOI: https://doi.org/10.1128/AAC.02063-19       
37.
A Potent Host Defense Peptide Triggers DNA Damage and Is Active against Multidrug-Resistant Gram-Negative Pathogens
Juliano SA
ACS Publications, American Chemical Society, 6 Apr. 2020,
DOI: https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.0c00051       
38.
In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa
Asempa TE, Nicolau DP, Kuti JL
Antimicrobial Agents and Chemotherapy, 64(5), 2020
DOI: https://doi.org/10.1128/AAC.00467-20       
39.
Feasibility and potential significance of rapid in vitro qualitative phenotypic antimicrobial susceptibility testing of gram-negative bacilli with the ProMax system
Chen J, Tomasek M, Cruz A, Faron ML, Liu D, et al.
PLOS ONE 16(3): e0249203
DOI: https://doi.org/10.1371/journal.pone.0249203       
40.
Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris
Rybak JM, Muñoz JF, Barker KS, Parker JE, Esquivel BD, Berkow EL, Lockhart SR, Gade L, Palmer GE, White TC, Kelly SL, Cuomo CA, Rogers PD
mBIO Therapeutics and Prevention May/June 2020 Volume 11 Issue 3 e00365-20
DOI: https://doi.org/10.1128/mBio.00365-20       
41.
Bacteria Broadly-Resistant to Last Resort Antibiotics Detected in Commercial Chicken Farms
Jochum JM, Redweik GAJ, Ott LC, Mellata M
Microorganisms. 2021; 9(1):141.
DOI: https://doi.org/10.3390/microorganisms9010141       
42.
A culture collection of 50 Neisseria gonorrhoeae isolates.
Liu H, Vidyaprakash E, Schmerer MW, Pham DC, St Cyr S, Kersh EN
Microbiology Resource Announcements. 2020;9(40).
DOI: https://doi.org/10.1128/mra.00699-20       
43.
Characterization of a Neisseria gonorrhoeae ciprofloxacin panel for an antimicrobial resistant isolate bank
Liu H, Tang K, Pham CD, Schmerer M, Kersh EN, Raphael BH
PLOS ONE. 2022;17(3).
DOI: https://doi.org/10.1371/journal.pone.0264149       
44.
Evaluation of the Xpert Carba-R NxG assay for detection of Carbapenemase genes in a global challenge set of Pseudomonas aeruginosa isolates
Gill CM, Asempa TE, Tickler IA, dela Cruz C, Tenover FC, Nicolau DP
Journal of Clinical Microbiology, 2020 58(12).
DOI: https://doi.org/10.1128/jcm.01098-20       
45.
Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial Isolates
Simner PJ, Musser KA, Mitchell K, Wise MG, Lewis S, Yee R, Bergman Y, Good CE, Abdelhamed AM, Li H, Laseman EM, Sahm D, Pitzer K, Quan J, Walker GT, Jacobs MR, Rhoads DD
J Clin Microbiol. 2022 Mar 16;60(3):e0209821.
DOI: https://doi.org/10.1128/JCM.02098-21       
46.
Performance of the Reveal Rapid Antibiotic Susceptibility Testing System on Gram-Negative Blood Cultures at a Large Urban Hospital
Tibbetts R, George S, Burwell R, Rajeev L, Rhodes PA, Singh P, Samuel LJ
Clin Microbiol. 2022 Jun 15;60(6):e0009822.
DOI: https://doi.org/10.1128/jcm.00098-22       
47.
Microplate-based surface area assay for rapid phenotypic antibiotic susceptibility testing
Flentie K, Spears BR, Chen F, Purmort NB, DaPonte K, Viveiros E, Phelan N, Krebill C, Flyer AN, Hooper DC, Smalley DL, Ferraro MJ, Vacic A, Stern E
Sci Rep. 2019 Jan 18;9(1):237.
DOI: https://doi.org/10.1038/s41598-018-35916-0       
48.
Complete Genome Sequence of Escherichia coli Antibiotic-Resistant Isolate AR Bank #0349
Stuart KL, Shore SM, Nicholson TL
Microbiol Resour Announc. 2019 Nov 27;8(48):e01078-19.
DOI: https://doi.org/10.1128/MRA.01078-19       
49.
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report
Avery L, Cardo D, Capers K, Coffin N, Craig M
Contagion, February 2020, Volume 5, Issue 1.
https://www.contagionlive.com/view/five-ways-id-clinicians-can-take-on-antibiotic-resistance-highlights-from-the-cdcs-latest-report       
50.
Key Takeaways From the U.S. CDC's 2019 Antibiotic Resistance Threats Report for Frontline Providers
Kadri SS
Crit Care Med. 2020 Jul;48(7):939-945.
DOI: https://doi.org/10.1097/CCM.0000000000004371       
51.
Performance of the check-points check-MDR CT103XL assay utilizing the CDC/FDA antimicrobial resistance isolate bank
Powell EA, Haslam DB, Mortensen J
Diagnostic Microbiology and Infectious Disease, 88(3), 219–221. (2017).
DOI: https://doi.org/10.1016/j.diagmicrobio.2017.04.011       
52.
Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado M, McAllister G, Korhonen L, Guh A, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS
Microbiology Resource Announcements, 10(1). (2021)
DOI: https://doi.org/10.1128/mra.01011-20       
53.
Genotypic antimicrobial resistance assays for use on E. coli isolates and stool specimens
Pholwat S, Liu J, Taniuchi M, Chinli R, Pongpan T, et al.
PLOS ONE 14(5): e0216747 (2019)
DOI: https://doi.org/10.1371/journal.pone.0216747       
54.
The effect of transport temperature and time on the recovery of antimicrobial-resistant Enterobacterales in stool
Turbett SE, Becker M, Desrosiers L, Oliver E, Rao SR, Walker AT, Walters M, Ryan ET, LaRocque RC
Diagnostic Microbiology and Infectious Disease. 2021.
DOI: https://doi.org/10.1016/j.diagmicrobio.2020.115210       
55.
Multiplex Detection of Antimicrobial Resistance Genes for Rapid Antibiotic Guidance of Urinary Tract Infections
Harris M, Fasolino T, Davis NJ, Ivankovic D, Brownlee N
Microbiol. Res. 2023, 14, 591-602.
DOI: https://doi.org/10.3390/microbiolres14020041       
56.
Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
Witherell KS, Price J, Bandaranayake AD, Olson J, Call DR
Journal of Global Antimicrobial Resistance. 2020.
DOI: https://doi.org/10.1016/j.jgar.2020.05.013       
57.
Antimicrobial Resistance Laboratory Network’s multisite evaluation of the ThermoFisher Sensititre GN7F broth microdilution panel for antimicrobial susceptibility testing
Bhatnagar AS, Machado MJ, Patterson L, Anderson K, Abelman RL, Bateman A, Biggs A, Bumpus-White P, Craft B, Howard M, LaVoie SP, Lonsway D, Sabour S, Schneider A, Snippes-Vagnone P, Tran M, Torpey D, Valley A, Elkins CA, Karlsson M, Brown AC
Journal of Clinical Microbiology. 2023.
DOI: https://doi.org/10.1128/jcm.00799-23       
58.
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
Fouad A, Nicolau DP, Gill CM
Journal of Antimicrobial Chemotherapy. 2023.
DOI: https://doi.org/10.1093/jac/dkad244       
59.
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests
McLeod SM, Carter NM, Huband MD, Traczewski MM, Bradford PA, Miller AA
Journal of Clinical Microbiology. 2023.
DOI: https://doi.org/10.1128/jcm.01228-23       
60.
Characterizing conjugative plasmids from an antibiotic-resistant dataset for use as broad-host delivery vectors.
Loyola Irizarry HG, Brito IL
Frontiers in Microbiology. 2023.
DOI: https://doi.org/10.3389/fmicb.2023.1199640       
61.
Ultraviolet-C mediated inactivation of Candida auris, a rapid emerging health threat
Koutras C, Wade RL
American Journal of Infection Control. 2023.
DOI: https://doi.org/10.1016/j.ajic.2023.08.018       
62.
Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution Test
Harris H, Tao L, Jacobs EB, Bergman Y, Adebayo A, Tekle T, Lewis S, Dahlquist A, Abbey TC, Wenzler E, Humphries R, Simner P
Journal of Clinical Microbiology. 2023.
DOI: https://doi.org/10.1128/jcm.01647-22       

Top of Page

Page last reviewed: March 20, 2024
TOP